Meiting Chen

1.4k total citations
70 papers, 857 citations indexed

About

Meiting Chen is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Meiting Chen has authored 70 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 23 papers in Molecular Biology and 11 papers in Surgery. Recurrent topics in Meiting Chen's work include Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (9 papers) and HER2/EGFR in Cancer Research (8 papers). Meiting Chen is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (9 papers) and HER2/EGFR in Cancer Research (8 papers). Meiting Chen collaborates with scholars based in China, Taiwan and United States. Meiting Chen's co-authors include Shao-Peng Lin, Youming Long, Shan Ye, Haifeng Mao, Qingsong Yang, Shuhan Sun, Ya-Wei Hsueh, Ji‐hang Yuan, Fang Wang and Mei Huang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Meiting Chen

62 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meiting Chen China 16 462 248 140 94 76 70 857
Taicheng Zhou China 18 725 1.6× 343 1.4× 117 0.8× 103 1.1× 59 0.8× 70 1.2k
José Ignacio Arias Spain 19 381 0.8× 247 1.0× 167 1.2× 122 1.3× 114 1.5× 80 1.2k
Koji Kikuchi Japan 20 962 2.1× 205 0.8× 158 1.1× 69 0.7× 82 1.1× 41 1.2k
Sadie Johnson United States 19 369 0.8× 110 0.4× 234 1.7× 47 0.5× 91 1.2× 60 859
Jinliang Ma China 18 413 0.9× 220 0.9× 202 1.4× 84 0.9× 103 1.4× 60 926
Song Gu China 18 571 1.2× 279 1.1× 149 1.1× 199 2.1× 94 1.2× 53 989
Xiao Dong Zhao China 12 741 1.6× 220 0.9× 79 0.6× 56 0.6× 143 1.9× 35 1.2k
Agatha Labrinidis Australia 18 394 0.9× 162 0.7× 301 2.1× 60 0.6× 101 1.3× 30 812
Jason P. Ross Australia 14 725 1.6× 336 1.4× 120 0.9× 52 0.6× 27 0.4× 32 1.0k

Countries citing papers authored by Meiting Chen

Since Specialization
Citations

This map shows the geographic impact of Meiting Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiting Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiting Chen more than expected).

Fields of papers citing papers by Meiting Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiting Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiting Chen. The network helps show where Meiting Chen may publish in the future.

Co-authorship network of co-authors of Meiting Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Meiting Chen. A scholar is included among the top collaborators of Meiting Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiting Chen. Meiting Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Meiting, Xiujuan Chen, Ke Ming, et al.. (2025). De novo designed mini-binders targeting glyceraldehyde-3-phosphate dehydrogenase of Streptococcus equi ssp. zooepidemicus provided partial protection in mice model of infection. International Journal of Biological Macromolecules. 307(Pt 3). 142293–142293. 1 indexed citations
2.
Wei, Lin, Yun You, Yang Hu, et al.. (2025). Rapid discovery of pseudorabies virus inhibitors repurposed from the antimicrobial agent ciprofloxacin. European Journal of Medicinal Chemistry. 289. 117490–117490. 1 indexed citations
3.
Li, Xudong, et al.. (2025). SLC31A1 promotes chemoresistance through inducing CPT1A-mediated fatty acid oxidation in ER-positive breast cancer. Neoplasia. 61. 101125–101125. 3 indexed citations
4.
Xue, Cong, Wei Yang, Anqi Hu, et al.. (2025). CYP2D6 polymorphisms and endoxifen concentration in Chinese patients with breast cancer. BMC Cancer. 25(1). 410–410. 1 indexed citations
5.
Fan, Mingyuan, et al.. (2025). Construction of a novel gene signature linked to ferroptosis in pediatric sepsis. Frontiers in Cell and Developmental Biology. 13. 1488904–1488904. 2 indexed citations
6.
Yang, Fan, Meiting Chen, Feng Wen, et al.. (2024). Sodium butyrate impedes the lymphoma caused by Marek’s disease virus via regulating the mitochondrial apoptosis pathway. Frontiers in Veterinary Science. 11. 1 indexed citations
7.
Chen, Meiting, et al.. (2024). Salt-in-metal-assisted formation of LiF-rich interphase for lithium metal anodes. Journal of Energy Storage. 101. 113708–113708.
8.
Lu, Yongkui, Lixia Li, Meiting Chen, et al.. (2024). Eribulin plus carboplatin combination for HER2-negative metastatic breast cancer: a multicenter, real-world cohort study. BMC Cancer. 24(1). 1214–1214.
9.
Chen, Meiting, et al.. (2024). Optimal Sequential Strategies for Antibody-Drug Conjugate in Metastatic Breast Cancer: Evaluating Efficacy and Cross-Resistance. The Oncologist. 29(8). e957–e966. 22 indexed citations
10.
Dong, Ying, Chengyue Zhu, Lan Yang, et al.. (2024). Targeting CCL2-CCR2 signaling pathway alleviates macrophage dysfunction in COPD via PI3K-AKT axis. Cell Communication and Signaling. 22(1). 364–364. 13 indexed citations
11.
Huang, He, Zhao Wang, Xiaojie Fang, et al.. (2023). A study on the prevention of hemorrhage and perforation in patients with primary gastric diffuse large‐B cell lymphoma during treatment with immunochemotherapy. Cancer Medicine. 12(6). 6924–6934. 1 indexed citations
12.
Wang, Pei, Meiting Chen, Ruili Liu, et al.. (2023). Fingerstick blood assay maps real‐world NAD + disparity across gender and age. Aging Cell. 22(10). e13965–e13965. 6 indexed citations
14.
Jiang, Kuikui, Ruoxi Hong, Qianyi Lu, et al.. (2023). Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study. Cancer Research and Treatment. 56(2). 513–521. 2 indexed citations
15.
Liu, Meng, Bang Xiao, Yiqing Zhu, et al.. (2023). MicroRNA-144-3p protects against chemotherapy-induced apoptosis of ovarian granulosa cells and activation of primordial follicles by targeting MAP3K9. European journal of medical research. 28(1). 264–264. 7 indexed citations
17.
Tang, Xiaoyan, Huilin Jiang, Peiyi Lin, et al.. (2021). Insulin-like growth factor binding protein-1 regulates HIF-1α degradation to inhibit apoptosis in hypoxic cardiomyocytes. Cell Death Discovery. 7(1). 242–242. 15 indexed citations
18.
Chen, Meiting, Cong Xue, Li Lü, et al.. (2021). Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor. Frontiers in Oncology. 11. 739134–739134. 5 indexed citations
19.
Huang, He, Li Min Chen, Xiao Lin, et al.. (2020). Prognostic Value of the Modified Systemic Inflammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma. Frontiers in Pharmacology. 11. 593392–593392. 13 indexed citations
20.
Lin, Shao-Peng, Shan Ye, Xiaohong Chen, et al.. (2016). Increased expression of microRNA-21 in peripheral blood mediates the down-regulation of IFN-γ and increases the prevalence of stroke-associated infection. Journal of the Neurological Sciences. 366. 235–239. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026